CCCC C4 Therapeutics, Inc. - Common Stock
C4 Therapeutics, Inc. - Common Stock 정보 위키백과 회사 개요
CCCC 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
CCCC 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
10년 성과 매출, 순이익, 마진 및 EPS 추세
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
CCCC 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
- 적극 매수 4 30.8%
- 매수 8 61.5%
- 보유 1 7.7%
- 매도 0 0.0%
- 적극 매도 0 0.0%
12개월 목표 주가
6 명의 애널리스트 · 2026-08-19실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
| 기간 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|
| 2026년 3월 31일 | $-0.20 | $-0.38 | 0.18% |
| 2025년 12월 31일 | $-0.18 | $-0.31 | 0.13% |
| 2025년 9월 30일 | $-0.44 | $-0.41 | -0.03% |
| 2025년 6월 30일 | $-0.37 | $-0.39 | 0.02% |
| 2025년 3월 31일 | $-0.37 | $-0.46 | 0.09% |
동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업
| 티커 | 시가총액 | P/E | 매출 YoY | 순이익률 | ROE | 매출 총이익률 |
|---|---|---|---|---|---|---|
| CCCC | $185M | -1.5 | 1.0% | -292.1% | -48.8% | — |
| PRLD | — | -2.2 | 73.4% | -819.6% | -137.7% | — |
| KYTX | $568M | -2.6 | — | — | -77.4% | — |
| VSTM | $600M | -2.6 | 209.1% | -677.6% | -449.2% | — |
| ZURA | — | — | — | — | — | — |
| EVMN | $540M | -1.5 | 85.7% | -529.8% | -401.2% | — |
| MPLT | $773M | -0.9 | — | — | -151.1% | — |
| CABA | $220M | -1.0 | — | — | -115.5% | — |
| QTTB | $43M | 1.4 | — | 55.5% | 200.3% | — |
| OCGN | $422M | -5.6 | 8.8% | -1537.4% | 1488.8% | — |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서 14
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue | $36M | $36M | $21M | $31M | $46M | |
| R&D Expense | $104M | $111M | $118M | $118M | $95M | |
| SG&A Expense | $36M | $42M | $42M | $43M | $33M | |
| Operating Expenses | $151M | $155M | $160M | $161M | $128M | |
| Operating Income | $-115M | $-120M | $-139M | $-130M | $-82M | |
| Other Non-op | $10M | $14M | $8M | $1M | $-2M | |
| Pretax Income | $-105M | $-105M | $-131M | $-128M | $-84M | |
| Income Tax | $121.0K | $131.0K | $1M | $0 | $0 | |
| Net Income | $-105M | $-105M | $-132M | $-128M | $-84M | |
| EPS (Basic) | $-1.27 | $-1.52 | $-2.67 | $-2.62 | $-1.82 | |
| EPS (Diluted) | $-1.27 | $-1.52 | $-2.67 | $-2.62 | $-1.82 | |
| Shares (Basic) | 82,894,459 | 69,372,993 | 49,640,505 | 48,861,665 | 46,041,733 | |
| Shares (Diluted) | 82,894,459 | 69,372,993 | 49,640,505 | 48,861,665 | 46,041,733 | |
| EBITDA | $-115M | $-120M | $-139M | $-130M | $-82M |
대차대조표 22
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $75M | $55M | $127M | $30M | $76M | |
| Short-term Investments | · | · | · | · | $233M | |
| Receivables | $2M | $3M | $12M | $1M | $6M | |
| Prepaid Expense | $7M | $10M | $6M | $10M | $11M | |
| Current Assets | $258M | $258M | $271M | $288M | $326M | |
| PP&E (Net) | $5M | $6M | $7M | $7M | $3M | |
| PP&E (Gross) | $16M | $15M | $15M | $16M | $10M | |
| Accum. Depreciation | $11M | $9M | $8M | $8M | $7M | |
| Other Non-current Assets | $4M | $3M | $3M | $2M | $544.0K | |
| Total Assets | $359M | $350M | $376M | $431M | $507M | |
| Accounts Payable | $858.0K | $1M | $1M | $1M | $5M | |
| Current Liabilities | $33M | $45M | $43M | $45M | $51M | |
| Capital Leases | $54M | $60M | $66M | $71M | $31M | |
| Total Liabilities | $102M | $134M | $130M | $142M | $117M | |
| Long-term Debt | · | · | $0 | $11M | $11M | |
| Total Debt | · | · | $0 | $11M | $11M | |
| Common Stock | $9.0K | $7.0K | $6.0K | $5.0K | $5.0K | |
| Retained Earnings | $-739M | $-634M | $-528M | $-396M | $-268M | |
| AOCI | $50.0K | $53.0K | $-127.0K | $-4M | $-775.0K | |
| Stockholders' Equity | $257M | $216M | $246M | $289M | $390M | |
| Liabilities + Equity | $359M | $350M | $376M | $431M | $507M | |
| Shares Outstanding | 96,914,418 | 70,625,899 | 60,467,188 | 48,966,216 | 48,688,875 |
현금 흐름 13
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $1M | |
| Stock-based Comp | $19M | $30M | $27M | $30M | $22M | |
| Restructuring | $0 | $2M | $0 | · | · | |
| Operating Cash Flow | $-99M | $-65M | $-107M | $-106M | $-87M | |
| CapEx | $607.0K | $180.0K | $2M | $5M | $1M | |
| Investing Cash Flow | $-9M | $-51M | $158M | $58M | $-189M | |
| Stock Issued | · | · | $58M | $0 | · | |
| Stock Repurchased | $193.0K | $194.0K | $110.0K | $0 | · | |
| Net Stock Activity | $-193.0K | $-194.0K | $58M | · | · | |
| Financing Cash Flow | $126M | $45M | $45M | $1M | $171M | |
| Net Change in Cash | $19M | $-71M | $97M | $-46M | $-105M | |
| Taxes Paid | $131.0K | $76.0K | · | · | · | |
| Free Cash Flow | $-99M | $-65M | $-109M | $-111M | $-88M |
수익성 7
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Operating Margin | -320.5% | -336.1% | -669.8% | -416.6% | · | |
| Net Margin | -292.1% | -296.0% | -638.3% | -412.2% | · | |
| Pretax Margin | -291.7% | -295.6% | -632.2% | · | · | |
| EBITDA Margin | -320.5% | -336.1% | -669.8% | -416.6% | · | |
| ROA | -29.6% | -29.0% | -32.8% | -27.3% | -18.5% | |
| ROE | -48.8% | -45.9% | -57.3% | -42.2% | -21.3% | |
| ROIC | -45.0% | -55.5% | -57.0% | · | · |
유동성 및 지급능력 4
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 7.8 | 5.7 | 6.3 | 6.5 | 6.4 | |
| Quick Ratio | 2.3 | 1.3 | 3.2 | 0.7 | 6.1 | |
| Debt / Equity | · | · | 0.0 | 0.0 | 0.0 | |
| LT Debt / Equity | · | · | 0.0 | 0.0 | 0.0 |
효율성 2
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | 0.1 | 0.1 | · | |
| Receivables Turnover | 13.1 | 4.8 | 3.1 | 8.7 | · |
성장률 2
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue YoY | 1.0% | 71.4% | -33.2% | -32.1% | · | |
| Revenue CAGR 3Y | 5.0% | -8.1% | · | · | · |
가치 평가 (TTM) 14
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue TTM | $36M | $36M | $21M | $31M | $46M | |
| Net Income TTM | $-105M | $-105M | $-132M | $-128M | $-84M | |
| Market Cap | $185M | $254M | $342M | $289M | $1.57B | |
| Enterprise Value | · | · | $215M | $271M | $1.27B | |
| P/E | -1.5 | -2.4 | -2.1 | -2.3 | -17.7 | |
| P/S | 5.1 | 7.1 | 16.5 | 9.3 | 34.2 | |
| P/B | 0.7 | 1.2 | 1.4 | 1.0 | 4.0 | |
| P / Tangible Book | 0.7 | 1.2 | 1.4 | 1.0 | 4.0 | |
| P / Cash Flow | -1.9 | -3.9 | -3.2 | -2.7 | -18.0 | |
| P / FCF | -1.9 | -3.9 | -3.1 | -2.6 | -17.8 | |
| EV / EBITDA | · | · | -1.5 | -2.1 | -15.5 | |
| EV / FCF | · | · | -2.0 | -2.4 | -14.4 | |
| EV / Revenue | · | · | 10.4 | 8.7 | 27.7 | |
| Earnings Yield | -66.5% | -42.2% | -47.3% | -44.4% | -5.7% |
손익계산서 14
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7M | $6M | $11M | $11M | $6M | $7M | $5M | $15M | $12M | $3M | $3M | $11M | $3M | $4M | $3M | $7M | |
| R&D Expense | $24M | $25M | $25M | $26M | $26M | $27M | $33M | $32M | $24M | $23M | $30M | $28M | $30M | $29M | $31M | $30M | |
| SG&A Expense | $9M | $9M | $9M | $9M | $9M | $9M | $10M | $12M | $10M | $10M | $10M | $11M | $10M | $11M | $10M | $10M | |
| Operating Expenses | $33M | $34M | $34M | $46M | $35M | $36M | $43M | $44M | $33M | $35M | $41M | $39M | $40M | $40M | $41M | $39M | |
| Operating Income | $-26M | $-28M | $-23M | $-34M | $-29M | $-29M | $-38M | $-28M | $-21M | $-32M | $-37M | $-28M | $-38M | $-36M | $-38M | $-32M | |
| Other Non-op | $3M | $3M | $3M | $2M | $2M | $3M | $3M | $4M | $4M | $4M | $3M | $2M | $2M | $1M | $1M | $530.0K | |
| Pretax Income | · | · | $-20M | $-32M | $-26M | $-26M | $-34M | $-25M | $-18M | $-28M | $-34M | $-26M | $-36M | $-35M | $-37M | $-32M | |
| Income Tax | $0 | $0 | $121.0K | $0 | $0 | $0 | $131.0K | $0 | $0 | $0 | $277.0K | $1M | $0 | $0 | $0 | $0 | |
| Net Income | $-24M | $-25M | $-20M | $-32M | $-26M | $-26M | $-35M | $-25M | $-18M | $-28M | $-35M | $-27M | $-36M | $-35M | $-37M | $-32M | |
| EPS (Basic) | $-0.18 | $-0.20 | $-0.09 | $-0.44 | $-0.37 | $-0.37 | $-0.50 | $-0.35 | $-0.26 | $-0.41 | $-0.68 | $-0.55 | $-0.73 | $-0.71 | $-0.76 | $-0.65 | |
| EPS (Diluted) | $-0.18 | $-0.20 | $-0.09 | $-0.44 | $-0.37 | $-0.37 | $-0.50 | $-0.35 | $-0.26 | $-0.41 | $-0.68 | $-0.55 | $-0.73 | $-0.71 | $-0.76 | $-0.65 | |
| Shares (Basic) | 130,696,742 | 126,074,555 | -131,507,639 | 72,563,311 | 71,005,743 | 70,833,044 | -137,496,624 | 69,627,190 | 68,810,259 | 68,432,168 | -97,667,571 | 49,212,126 | 49,063,631 | 49,032,319 | -97,618,788 | 48,921,928 | |
| Shares (Diluted) | 130,696,742 | 126,074,555 | -131,507,639 | 72,563,311 | 71,005,743 | 70,833,044 | -137,496,624 | 69,627,190 | 68,810,259 | 68,432,168 | -97,667,571 | 49,212,126 | 49,063,631 | 49,032,319 | -97,618,788 | 48,921,928 | |
| EBITDA | $-26M | $-27M | · | $-34M | $-29M | $-29M | · | $-28M | $-21M | $-32M | · | $-28M | $-38M | $-36M | · | $-32M |
대차대조표 22
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $79M | $61M | $75M | $59M | $78M | $51M | $55M | $60M | $73M | $90M | $127M | $61M | $45M | $49M | $30M | $50M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $264M | |
| Receivables | $1M | $3M | $2M | $7M | $2M | $8M | $3M | $10M | $1M | $14M | $12M | $500.0K | $1M | $528.0K | $1M | $1M | |
| Prepaid Expense | $8M | $7M | $7M | $8M | $8M | $9M | $10M | $7M | $11M | $8M | $6M | $7M | $6M | $8M | $10M | $10M | |
| Current Assets | $263M | $245M | $258M | $207M | $225M | $233M | $258M | $273M | $276M | $280M | $271M | $224M | $274M | $278M | $288M | $325M | |
| PP&E (Net) | $4M | $4M | $5M | $5M | $6M | $5M | $6M | $6M | $7M | $7M | $7M | $7M | $8M | $8M | $7M | $7M | |
| PP&E (Gross) | $16M | $16M | $16M | $16M | $16M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $16M | $16M | $15M | |
| Accum. Depreciation | $11M | $11M | $11M | $10M | $10M | $10M | $9M | $9M | $9M | $8M | $8M | $8M | $8M | $9M | $8M | $8M | |
| Other Non-current Assets | $4M | $4M | $4M | $211.0K | $178.0K | $3M | $3M | $5M | $3M | $5M | $3M | $3M | $3M | $3M | $2M | $1M | |
| Total Assets | $359M | $329M | $359M | $265M | $297M | $320M | $350M | $376M | $381M | $398M | $376M | $333M | $375M | $396M | $431M | $461M | |
| Accounts Payable | $1M | $773.0K | $858.0K | $1M | $2M | $683.0K | $1M | $2M | $913.0K | $2M | $1M | $1M | $2M | $1M | $1M | $2M | |
| Current Liabilities | $48M | $27M | $33M | $36M | $44M | $41M | $45M | $43M | $54M | $55M | $43M | $30M | $48M | $39M | $45M | $45M | |
| Capital Leases | $50M | $52M | $54M | $55M | $57M | $58M | $60M | $61M | $63M | $64M | $66M | $67M | $68M | $70M | $71M | $72M | |
| Total Liabilities | $112M | $95M | $102M | $111M | $122M | $124M | $134M | $133M | $134M | $140M | $130M | $117M | $141M | $134M | $142M | $143M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | $10M | $12M | $11M | $11M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | $11M | · | $11M | |
| Common Stock | $12.0K | $10.0K | $9.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $6.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | |
| Retained Earnings | $-787M | $-764M | $-739M | $-718M | $-686M | $-660M | $-634M | $-599M | $-574M | $-557M | $-528M | $-494M | $-467M | $-431M | $-396M | $-359M | |
| AOCI | $-444.0K | $-322.0K | $50.0K | $87.0K | $-30.0K | $43.0K | $53.0K | $455.0K | $-440.0K | $-380.0K | $-127.0K | $-904.0K | $-2M | $-2M | $-4M | $-5M | |
| Stockholders' Equity | $247M | $234M | $257M | $154M | $174M | $195M | $216M | $243M | $247M | $258M | $246M | $216M | $234M | $262M | $289M | $318M | |
| Liabilities + Equity | $359M | $329M | $359M | $265M | $297M | $320M | $350M | $376M | $381M | $398M | $376M | $333M | $375M | $396M | $431M | $461M | |
| Shares Outstanding | 122,905,756 | 104,036,350 | 96,914,418 | 74,174,515 | 71,007,083 | 70,989,661 | 70,625,899 | 70,562,901 | 68,815,642 | 68,778,591 | 60,467,188 | 49,259,870 | 49,065,098 | 49,052,509 | 48,966,216 | 48,951,283 |
현금 흐름 11
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $292.0K | $404.0K | · | $460.0K | $615.0K | $456.0K | · | $442.0K | $448.0K | $448.0K | · | $447.0K | · | · | · | · | |
| Stock-based Comp | $3M | $3M | $4M | $5M | $5M | $6M | $8M | $9M | $6M | $6M | $6M | $8M | $6M | $6M | $7M | $6M | |
| Other Non-cash | · | $-8M | · | · | · | $-13M | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-2M | $-30M | $-22M | $-31M | $-12M | $-33M | $-18M | $-24M | $-5M | $-18M | $-24M | $-31M | $-19M | $-33M | $-29M | $-28M | |
| CapEx | $37.0K | $64.0K | $11.0K | $411.0K | $185.0K | $0 | $-4.0K | $-13.0K | $197.0K | $0 | $157.0K | $600.0K | $362.0K | $589.0K | $1M | $3M | |
| Investing Cash Flow | $-15M | $16M | $-81M | $4M | $39M | $29M | $14M | $162.0K | $-12M | $-53M | $32M | $58M | $15M | $54M | $9M | $20M | |
| Stock Repurchased | $0 | $200.0K | $14.0K | $24.0K | $0 | $155.0K | $0 | $85.0K | $0 | $109.0K | $0 | $16.0K | $0 | $94.0K | $0 | $0 | |
| Net Stock Activity | · | $-200.0K | · | · | · | $-155.0K | · | · | · | $-109.0K | · | · | · | $-94.0K | · | · | |
| Financing Cash Flow | $34M | $462.0K | $119M | $8M | $0 | $-46.0K | $112.0K | $11M | $135.0K | $35M | $58M | $-11M | $-746.0K | $-684.0K | $47.0K | $361.0K | |
| Net Change in Cash | $17M | $-13M | $16M | $-19M | $27M | $-4M | $-4M | $-13M | $-17M | $-37M | $66M | $16M | $-5M | $20M | $-20M | $-8M | |
| Free Cash Flow | · | $-30M | · | · | · | · | · | · | · | $-18M | · | · | · | $-34M | · | · |
수익성 7
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -397.9% | -451.6% | · | -306.4% | -441.0% | -402.9% | · | -183.9% | -178.6% | -1060.2% | · | -251.2% | -1410.2% | -963.8% | · | -481.0% | |
| Net Margin | -355.9% | -408.5% | · | -286.4% | -402.6% | -363.7% | · | -160.6% | -147.6% | -933.2% | · | -244.2% | -1348.4% | -925.2% | · | -473.2% | |
| Pretax Margin | · | · | · | -286.4% | -402.6% | -363.7% | · | -160.6% | -147.6% | -933.2% | · | -235.1% | · | · | · | · | |
| EBITDA Margin | -397.9% | -445.1% | · | -306.4% | -441.0% | -396.6% | · | -183.9% | -178.6% | -1060.2% | · | -251.2% | -1410.2% | -963.8% | · | -481.0% | |
| ROA | -7.2% | -7.8% | · | -8.8% | -6.6% | -7.6% | · | · | · | -7.8% | · | · | · | -7.6% | · | -6.6% | |
| ROE | -11.2% | -11.7% | · | -13.6% | -10.0% | -12.0% | · | · | · | -12.0% | · | · | · | -11.1% | · | -8.9% | |
| ROIC | · | · | · | -22.3% | · | -14.9% | · | · | · | -12.5% | · | · | · | · | · | · |
유동성 및 지급능력 4
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.4 | 9.0 | · | 5.8 | 5.1 | 5.7 | · | · | · | 5.1 | · | · | · | 7.1 | · | 7.2 | |
| Quick Ratio | 1.7 | 2.4 | · | 1.8 | 1.8 | 1.5 | · | · | · | 1.9 | · | · | · | 1.3 | · | 7.0 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 | · | 0.0 | |
| LT Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 | · | 0.0 |
효율성 2
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | · | 0.0 | · | · | · | 0.0 | · | 0.0 | |
| Receivables Turnover | 3.8 | 1.1 | · | 2.8 | 3.3 | 0.8 | · | · | · | 0.4 | · | · | · | 3.3 | · | 2.1 |
가치 평가 (TTM) 14
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $30M | $31M | · | $40M | $41M | $38M | · | $41M | $29M | $21M | · | $24M | $27M | $32M | · | $37M | |
| Net Income TTM | $-107M | $-110M | · | $-109M | $-95M | $-97M | · | $-98M | $-109M | $-126M | · | $-130M | $-130M | $-126M | · | $-116M | |
| Market Cap | $574M | $274M | · | $165M | $102M | $114M | · | · | · | $562M | · | · | · | $154M | · | $429M | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | · | · | $115M | · | $127M | |
| P/E | -3.9 | -1.9 | · | -1.5 | -1.1 | -1.2 | · | -3.6 | -2.4 | -3.4 | · | -0.7 | -1.0 | -1.2 | · | -3.7 | |
| P/S | 18.8 | 8.8 | · | 4.1 | 2.5 | 3.0 | · | · | · | 27.4 | · | · | · | 4.8 | · | 11.7 | |
| P/B | 2.3 | 1.2 | · | 1.1 | 0.6 | 0.6 | · | · | · | 2.2 | · | · | · | 0.6 | · | 1.3 | |
| P / Tangible Book | 2.3 | 1.2 | · | 1.1 | 0.6 | 0.6 | · | · | · | 2.2 | · | · | · | 0.6 | · | 1.3 | |
| P / Cash Flow | · | -9.1 | · | · | · | -3.4 | · | · | · | -31.0 | · | · | · | -4.6 | · | · | |
| P / FCF | · | -9.1 | · | · | · | · | · | · | · | -31.0 | · | · | · | -4.6 | · | · | |
| EV / EBITDA | · | · | · | · | · | · | · | · | · | · | · | · | · | -3.2 | · | -3.9 | |
| EV / FCF | · | · | · | · | · | · | · | · | · | · | · | · | · | -3.4 | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | · | · | 3.6 | · | 3.5 | |
| Earnings Yield | -25.5% | -52.5% | · | -68.9% | -94.4% | -86.9% | · | -27.5% | -42.2% | -29.4% | · | -141.9% | -96.4% | -81.8% | · | -27.0% |
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
손익계산서
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 매출 | $36M | $36M | $21M | $31M | $46M |
| 영업이익률 % | -320.5% | -336.1% | -669.8% | -416.6% | — |
| 순이익 | $-105M | $-105M | $-132M | $-128M | $-84M |
| 희석 EPS | $-1.27 | $-1.52 | $-2.67 | $-2.62 | $-1.82 |
대차대조표
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 부채 / 자기자본 비율 | — | — | 0.0 | 0.0 | 0.0 |
| 유동비율 | 7.8 | 5.7 | 6.3 | 6.5 | 6.4 |
| 당좌 비율 | 2.3 | 1.3 | 3.2 | 0.7 | 6.1 |
현금 흐름
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 잉여현금흐름 | $-99M | $-65M | $-109M | $-111M | $-88M |
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.
기관 투자자 (13F) 164개의 제출자 · $417.2M 전체 · 기준일 2026년 6월 30일
분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
| 신규 포지션 | 청산 포지션 | 증가함 | 감소 | 순주식 변동 |
|---|---|---|---|---|
| 59 (+26 이전 분기 대비) | 25 (+16 이전 분기 대비) | 51 (+11 이전 분기 대비) | 29 (-2 이전 분기 대비) | +22.0M |
Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
| 기관 | 가치 | 주식 | % 추적된 13F 중 | 유형 |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $37,360,000 | 8,000,000 | 8.96% | 주식 |
| Lynx1 Capital Management LP | $34,215,647 | 7,326,691 | 8.20% | 주식 |
| Squadron Capital Management LLC | $33,624,000 | 7,200,000 | 8.06% | 주식 |
| Bain Capital Life Sciences Investors, LLC | $33,492,820 | 7,171,910 | 8.03% | 주식 |
| VANGUARD CAPITAL MANAGEMENT LLC | $20,630,804 | 4,417,731 | 4.95% | 주식 |
| CITADEL ADVISORS LLC | $17,934,243 | 3,840,309 | 4.30% | 주식 |
| TWO SIGMA INVESTMENTS, LP | $16,203,532 | 3,469,707 | 3.88% | 주식 |
| Soleus Capital Management, L.P. | $15,775,171 | 3,377,981 | 3.78% | 주식 |
| GOLDMAN SACHS GROUP INC | $14,897,020 | 3,189,940 | 3.57% | 주식 |
| SILVERARC CAPITAL MANAGEMENT, LLC | $14,159,720 | 3,032,060 | 3.39% | 주식 |
| Ikarian Capital, LLC | $11,362,110 | 2,433,000 | 2.72% | 주식 |
| GEODE CAPITAL MANAGEMENT, LLC | $10,078,978 | 2,157,769 | 2.42% | 주식 |
| STATE STREET CORP | $9,879,950 | 2,115,621 | 2.37% | 주식 |
| Candriam S.C.A. | $8,383,622 | 1,796,937 | 2.01% | 주식 |
| D. E. Shaw & Co., Inc. | $8,130,419 | 1,740,989 | 1.95% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $8,089,421 | 1,732,210 | 1.94% | 주식 |
| WASATCH ADVISORS LP | $7,789,431 | 2,961,761 | 1.87% | 주식 |
| Patient Square Capital LP | $7,513,166 | 1,608,815 | 1.80% | 주식 |
| VANGUARD GROUP INC | $7,376,137 | 3,861,852 | 1.77% | 주식 |
| HighVista Strategies LLC | $6,295,800 | 1,348,136 | 1.51% | 주식 |
| BANK OF AMERICA CORP /DE/ | $5,691,848 | 1,218,811 | 1.36% | 주식 |
| RENAISSANCE TECHNOLOGIES LLC | $5,556,497 | 1,189,828 | 1.33% | 주식 |
| DIMENSIONAL FUND ADVISORS LP | $4,982,633 | 1,066,945 | 1.19% | 주식 |
| CONGRESS ASSET MANAGEMENT CO | $4,686,051 | 1,003,437 | 1.12% | 주식 |
| FMR LLC | $4,172,187 | 893,402 | 1.00% | 주식 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $3,647,550 | 781,060 | 0.87% | 주식 |
| BOOTHBAY FUND MANAGEMENT, LLC | $3,438,666 | 736,331 | 0.82% | 주식 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $3,176,039 | 680,094 | 0.76% | 주식 |
| VANGUARD FIDUCIARY TRUST CO | $2,844,712 | 609,146 | 0.68% | 주식 |
| ExodusPoint Capital Management, LP | $2,709,511 | 580,195 | 0.65% | 주식 |
| Velan Capital Investment Management LP | $2,661,900 | 570,000 | 0.64% | 주식 |
| STEMPOINT CAPITAL LP | $2,445,436 | 523,648 | 0.59% | 주식 |
| Rockefeller Capital Management L.P. | $2,315,465 | 495,817 | 0.56% | 주식 |
| TWO SIGMA ADVISERS, LP | $2,040,262 | 1,068,200 | 0.49% | 주식 |
| Man Group plc | $1,908,386 | 408,648 | 0.46% | 주식 |
| Squadron Capital Management LLC | $1,868,000 | 400,000 | 0.45% | 콜 옵션 |
| PLATINUM INVESTMENT MANAGEMENT LTD | $1,796,857 | 384,766 | 0.43% | 주식 |
| Seven Fleet Capital Management LP | $1,780,059 | 381,169 | 0.43% | 주식 |
| Qube Research & Technologies Ltd | $1,730,487 | 370,554 | 0.41% | 주식 |
| Atom Investors LP | $1,701,519 | 364,351 | 0.41% | 주식 |
| Susquehanna Portfolio Strategies, LLC | $1,564,819 | 335,079 | 0.38% | 주식 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $1,517,750 | 325,000 | 0.36% | 주식 |
| Connor, Clark & Lunn Investment Management Ltd. | $1,404,428 | 300,734 | 0.34% | 주식 |
| ADAR1 Capital Management, LLC | $1,363,439 | 291,957 | 0.33% | 주식 |
| JANE STREET GROUP, LLC | $1,267,158 | 271,340 | 0.30% | 주식 |
| PANAGORA ASSET MANAGEMENT INC | $1,237,302 | 264,947 | 0.30% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1,210,931 | 259,300 | 0.29% | 콜 옵션 |
| LPL Financial LLC | $1,182,281 | 253,165 | 0.28% | 주식 |
| MARSHALL WACE, LLP | $1,007,118 | 215,657 | 0.24% | 주식 |
| MILLENNIUM MANAGEMENT LLC | $1,005,853 | 215,386 | 0.24% | 주식 |
| Jump Financial, LLC | $853,209 | 182,700 | 0.20% | 주식 |
| Caption Management, LLC | $825,656 | 176,800 | 0.20% | 콜 옵션 |
| Point72 Asset Management, L.P. | $812,417 | 173,965 | 0.19% | 주식 |
| Squarepoint Ops LLC | $797,795 | 170,834 | 0.19% | 주식 |
| Headlands Technologies LLC | $719,049 | 153,972 | 0.17% | 주식 |
| AMERICAN CENTURY COMPANIES INC | $703,680 | 150,681 | 0.17% | 주식 |
| XTX Topco Ltd | $632,495 | 135,438 | 0.15% | 주식 |
| Palumbo Wealth Management LLC | $618,388 | 132,417 | 0.15% | 주식 |
| RHUMBLINE ADVISERS | $615,859 | 131,877 | 0.15% | 주식 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $612,237 | 131,100 | 0.15% | 주식 |
| Walleye Capital LLC | $537,634 | 115,125 | 0.13% | 주식 |
| ALPS ADVISORS INC | $524,039 | 112,214 | 0.13% | 주식 |
| CANADA PENSION PLAN INVESTMENT BOARD | $474,005 | 101,500 | 0.11% | 주식 |
| WELLS FARGO & COMPANY/MN | $471,623 | 100,990 | 0.11% | 주식 |
| DEUTSCHE BANK AG\ | $461,737 | 98,873 | 0.11% | 주식 |
| BlackRock, Inc. | $457,039 | 97,867 | 0.11% | 주식 |
| Verition Fund Management LLC | $443,650 | 95,000 | 0.11% | 주식 |
| Bank of New York Mellon Corp | $410,026 | 87,800 | 0.10% | 주식 |
| Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group | $396,950 | 85,000 | 0.10% | 주식 |
| BNP PARIBAS FINANCIAL MARKETS | $347,322 | 74,373 | 0.08% | 주식 |
| WELLINGTON MANAGEMENT GROUP LLP | $340,784 | 72,973 | 0.08% | 주식 |
| CITADEL ADVISORS LLC | $336,707 | 72,100 | 0.08% | 풋 옵션 |
| Cubist Systematic Strategies, LLC | $307,819 | 138,657 | 0.07% | 주식 |
| CV Advisors LLC | $303,550 | 65,000 | 0.07% | 주식 |
| INTREPID FAMILY OFFICE LLC | $303,550 | 65,000 | 0.07% | 주식 |
| MetLife Investment Management, LLC | $286,705 | 61,393 | 0.07% | 주식 |
| BARCLAYS PLC | $283,454 | 60,697 | 0.07% | 주식 |
| Jain Global LLC | $268,815 | 57,562 | 0.06% | 주식 |
| JANE STREET GROUP, LLC | $234,901 | 50,300 | 0.06% | 콜 옵션 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $217,034 | 46,474 | 0.05% | 주식 |
| CITIGROUP INC | $203,332 | 43,540 | 0.05% | 주식 |
| SEI INVESTMENTS CO | $197,896 | 42,376 | 0.05% | 주식 |
| Invesco Ltd. | $188,715 | 40,410 | 0.05% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $178,861 | 38,300 | 0.04% | 풋 옵션 |
| Quadrature Capital Ltd | $171,510 | 36,726 | 0.04% | 주식 |
| ALLIANCEBERNSTEIN L.P. | $170,371 | 64,780 | 0.04% | 주식 |
| Caption Management, LLC | $163,450 | 35,000 | 0.04% | 주식 |
| Vanguard Global Advisers, LLC | $157,995 | 33,832 | 0.04% | 주식 |
| Dynamic Technology Lab Private Ltd | $153,000 | 32,828 | 0.04% | 주식 |
| PRUDENTIAL FINANCIAL INC | $145,867 | 31,235 | 0.03% | 주식 |
| Nuveen, LLC | $142,528 | 30,520 | 0.03% | 주식 |
| Police & Firemen's Retirement System of New Jersey | $139,600 | 29,893 | 0.03% | 주식 |
| UBS Group AG | $136,798 | 29,293 | 0.03% | 주식 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $128,486 | 27,513 | 0.03% | 주식 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $117,268 | 25,111 | 0.03% | 주식 |
| Cresset Asset Management, LLC | $116,750 | 25,000 | 0.03% | 주식 |
| CITADEL ADVISORS LLC | $114,882 | 24,600 | 0.03% | 콜 옵션 |
| NEW YORK STATE COMMON RETIREMENT FUND | $112,547 | 24,100 | 0.03% | 주식 |
| StoneX Group Inc. | $102,297 | 22,420 | 0.02% | 주식 |
| GROUP ONE TRADING LLC | $101,680 | 21,773 | 0.02% | 주식 |
회사 내부자 25 명의 내부자 · 11 임원 · 15 이사
| 내부자 | 역할 | 마지막 활동 | 보유 주식 수 | 매수 12개월 | 매도 12개월 | 순매수/매도 12개월 |
|---|---|---|---|---|---|---|
| Andrew Hirsch | President & CEO | 2022년 5월 26일 F | 18,825 | 0 | 0 | $0 |
| Lauren White | Chief Financial Officer | 2022년 5월 26일 F | 2,648 | 0 | 0 | $0 |
| William Mckee | Chief Financial Officer | 2020년 10월 6일 P | 5,263 | 0 | 0 | $0 |
| Leonard Reyno | Chief Medical Officer | 2026년 7월 10일 F | 372,406 | 0 | 0 | $0 |
| Paige Mahaney | Chief Scientific Officer | 2025년 10월 28일 F | 99,356 | 0 | 0 | $0 |
| Scott N Boyle | Chief Business Officer | 2022년 5월 26일 F | 2,648 | 0 | 0 | $0 |
| Adam Crystal | Chief Medical Officer | 2022년 5월 26일 F | 17,648 | 0 | 0 | $0 |
| Stewart Fisher | Chief Scientific Officer | 2022년 5월 26일 F | 74,038 | 0 | 0 | $0 |
| Kelly Schick | Chief People Officer | 2022년 5월 26일 F | 2,648 | 0 | 0 | $0 |
| Jolie Siegel | Chief Legal Officer | 2022년 5월 26일 F | 2,648 | 0 | 0 | $0 |
| Laura Jean Wahlberg | VP of Finance Corp Controller | 2021년 2월 11일 A | — | 0 | 0 | $0 |
| Kenneth Carl Anderson | 이사 | 2026년 7월 1일 A | 71,950 | 0 | 0 | $0 |
| Donna Roy Grogan | 이사 | 2026년 7월 1일 A | 74,853 | 0 | 0 | $0 |
| Stephen Fawell | 이사 | 2026년 6월 24일 A | — | 0 | 0 | $0 |
| Laura Bessen | 이사 | 2026년 6월 24일 A | — | 0 | 0 | $0 |
| Utpal Koppikar | 이사 | 2026년 6월 24일 A | — | 0 | 0 | $0 |
| Ronald Harold Wilfred Cooper | 이사 | 2026년 6월 24일 A | — | 0 | 0 | $0 |
| Owen Hughes | 이사 | 2026년 6월 24일 A | — | 0 | 0 | $0 |
| Steven L. Hoerter | 이사 | 2026년 6월 24일 A | — | 0 | 0 | $0 |
| Glenn Dubin | 이사 | 2022년 7월 1일 A | 2,245 | 0 | 0 | $0 |
| Malcolm Salter | 이사 | 2022년 6월 22일 A | 11,380 | 0 | 0 | $0 |
| Bruce Downey | 이사 | 2022년 6월 22일 A | 489,542 | 0 | 0 | $0 |
| Marc A Cohen | 이사 | 2022년 6월 22일 A | 1,118 | 0 | 0 | $0 |
| Alain J Cohen | 이사 | 2022년 4월 4일 A | 928 | 0 | 0 | $0 |
| Elena Prokupets | 이사 | 2021년 9월 27일 S | 503,126 | 0 | 0 | $0 |
SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당
행동주의자 및 5% 이상 소유자 1 보유
SEC 서류 13D를 제출한 투자자 — 발행인에 영향을 미치려는 의도로 5% 이상의 실질 소유권(행동주의 지분, 이사회 캠페인, M&A). 각 행은 해당 제출자의 포지션에 대한 가장 최근에 알려진 상태를 보여줍니다.
| 제출자 | 제출됨 | 지분 | 상태 | 목적 | 제출 |
|---|---|---|---|---|---|
| Cobro Ventures Opportunity Fund, L.P., Cobro Opportunity Fund GP, LLC, Marc Cohen, Alain Cohen, Todd Kaloudis ×2 제출 서류 | 2021년 6월 15일 | — | 최초 제출 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF 보유 현황 20 ETF 보유
가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.
| 펀드 | 비중 | 단위 | 기준일 | 출처 |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0.42% | 25,589 SH | 2026년 8월 8일 | 일간 |
| IWC · iShares Trust | 0.08% | 344,636 SH | 2026년 8월 8일 | 일간 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.03% | 88,122 SH | 2026년 8월 8일 | 일간 |
| IBB · iShares Trust | 0.03% | 731,107 SH | 2026년 8월 8일 | 일간 |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.03% | 5,955 SH | 2026년 8월 8일 | 일간 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.03% | 206,890 SH | 2026년 8월 8일 | 일간 |
| IWN · iShares Trust | 0.02% | 922,673 SH | 2026년 8월 8일 | 일간 |
| BIB · ProShares Trust | 0.02% | 3,609 NS | 2026년 5월 31일 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.02% | 115,035 NS | 2026년 5월 31일 | N-PORT |
| IWM · iShares Trust | 0.01% | 2,543,253 SH | 2026년 8월 8일 | 일간 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 583,446 SH | 2026년 8월 8일 | 일간 |
| SCHA · SCHWAB STRATEGIC TRUST | 0.01% | 377,039 NS | 2026년 5월 31일 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.01% | 321,952 NS | 2026년 4월 30일 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 7,360 NS | 2026년 4월 30일 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 19,202 NS | 2026년 4월 30일 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0.00% | 27,023 NS | 2026년 5월 31일 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 21,949 NS | 2026년 4월 30일 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 1,046,993 SH | 2026년 8월 8일 | 일간 |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 3,264,924 SH | 2026년 8월 8일 | 일간 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 8,526 SH | 2026년 8월 8일 | 일간 |